Non-Hodgkin lymphoma isn’t one disease — it’s a group of cancers that originate in cells of the immune system, called lymphocytes. The non-Hodgkin lymphomas (NHLs) are a diverse group of blood cancers that include any kind of lymphoma except Hodgkin lymphoma. They all start in lymph tissue and share some similarities in how the cells look under a microscope.
Children with lymphoblastic lymphoma are treated at Dana-Farber/Boston Children's through the Lymphoma Program in our Hematologic Malignancy Center. One of the top pediatric cancer centers worldwide, Dana-Farber/Boston Children’s combines the expertise of a premier cancer center — Dana-Farber Cancer Institute — and a world-class children’s hospital — Boston Children’s Hospital — to provide internationally-renowned care for children with cancer.
Find more in-depth information on non-Hodgkin lymphoma on the Dana-Farber website.
Practitioners Who Specialize In This Condition (6)
Attending Physician, Dana-Farber/Boston Children's Cancer and Blood Disorders Center; Director, Pediatric and Young Adult Cancer Health Outcomes Research Center, Dana-Farber Cancer Institute
Associate Professor of Pediatrics, Harvard Medical School
The Dana-Farber/Boston Children's Cancer and Blood Disorders Center is an integrated pediatric hematology and oncology program through Dana-Farber Cancer Institute and Boston Children’s Hospital.
The Hematopoietic (Stem) Cell Transplant Program at Dana-Farber/Boston Children's Cancer and Blood Disorders Center is one of the largest and most experienced pediatric stem cell transplant programs in the world.